Use of Eculizumab in Pediatric Patients with High-Risk Transplantation-Associated Thrombotic Microangiopathy: Outcomes and Risk Factors Associated with Response and Survival. A Retrospective Study on Behalf of the Spanish Group for Hematopoietic Transplantation and Cellular Therapy (GETH-TC)María Isabel Benítez‐Carabante, Cristina Díaz de Heredia, David Bueno et al.|Transplantation and Cellular Therapy|2024Cited by 13
Immune Reconstitution Profiling Suggests Antiviral Protection after Transplantation with Omidubicel: A Phase 3 SubstudyPaul Szabolcs, Mitchell E. Horwitz, Patrick J. Stiff et al.|Transplantation and Cellular Therapy|2023Cited by 10